Molecular Profiling of Bladder Tumors Based on the Detection of <i>FGFR3</i> and <i>TP53</i> Mutations

Abstract

Our data again represent solid proof for the pivotal role of FGFR3 and TP53 mutations in superficial and invasive bladder tumors, respectively. However, other molecular markers should be identified for borderline pT1G3 bladder tumors, which are probably at the crossroads of these 2 distinct molecular pathways.